The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Cytosorbents Corporation(NASDAQ:CTSO) 
Cytosorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSor...
Website: http://www.cytosorbents.com
Founded: 1997
Full Time Employees: 153
Sector: Healthcare
Industry: Medical Devices
Cytosorbents Days Payable Outstanding ttm (DPO)
Cytosorbents Days Receivable Outstanding ttm (DSO)
Cytosorbents Days Inventory Outstanding ttm (DIO)
Cytosorbents Op Cashflow Per Share ttm
Cytosorbents Free Cashflow Per Share ttm
Cytosorbents Cash Per Share ttm
Cytosorbents P/S ratio ttm
Cytosorbents (GAAP) P/E ratio ttm
Cytosorbents P/B ratio ttm
No extra charts and metrics for this ticker.